Keywords: CEST / APT / NOE, CEST / APT / NOE
Motivation: Application of quantitative CEST contrasts for breast imaging is limited due to pronounced fat-induced artifacts. The most prominent fat artifact appears in the Z-spectrum between [-2,-4] ppm, directly overlapping the rNOE signal at around -3.5 ppm, making accurate rNOE evaluation extremely challenging.
Goal(s): To investigate fat-corrected rNOE-CEST contrast (MTRRex) in breast cancer.
Approach: We retrospectively apply a novel postprocessing fat correction procedure on CEST data of patients with breast cancer.
Results: Fat-corrected MTRRex rNOE values showed 140% increase in tumor as compared to normal-appearing glandular tissue. Furthermore, a strong correlation (R2=0.71) between MTRRex rNOE and the tumor proliferation marker Ki-67 was found.
Impact: The significant elevation in fat-corrected MTRRex rNOE contrast along with the strong correlation with a tumor proliferation marker indicate the potential to use rNOE imaging as a valuable non-invasive imaging biomarker for breast cancer diagnosis, treatment planning, and monitoring.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords